Find information on thousands of medical conditions and prescription drugs.

Liposarcoma

Liposarcoma is a malignant tumor that arises in fat cells in deep soft tissue, such as that inside the thigh or in the retroperitoneum. more...

Home
Diseases
A
B
C
D
E
F
G
H
I
J
K
L
Amyotrophic lateral...
Bardet-Biedl syndrome
Labyrinthitis
Lafora disease
Landau-Kleffner syndrome
Langer-Giedion syndrome
Laryngeal papillomatosis
Laryngomalacia
Lassa fever
LCHAD deficiency
Leber optic atrophy
Ledderhose disease
Legg-Calvé-Perthes syndrome
Legionellosis
Legionnaire's disease
Leiomyoma
Leiomyosarcoma
Leishmaniasis
Lemierre's syndrome
Lennox-Gastaut syndrome
Leprechaunism
Leprophobia
Leprosy
Leptospirosis
Lesch-Nyhan syndrome
Leukemia
Leukocyte adhesion...
Leukodystrophy
Leukomalacia
Leukoplakia
LGS
Li-Fraumeni syndrome
Lichen planus
Ligyrophobia
Limb-girdle muscular...
Limnophobia
Linonophobia
Lipodystrophy
Lipoid congenital adrenal...
Liposarcoma
Lissencephaly
Lissencephaly syndrome...
Listeriosis
Liticaphobia
Liver cirrhosis
Lobster hand
Locked-In syndrome
Loiasis
Long QT Syndrome
Long QT syndrome type 1
Long QT syndrome type 2
Long QT syndrome type 3
LSA
Lung cancer
Lupus erythematosus
Lyell's syndrome
Lygophobia
Lyme disease
Lymphangioleiomyomatosis
Lymphedema
Lymphoma
Lymphosarcoma
Lysinuric protein...
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

They are typically large bulky tumors which tend to have multiple smaller satellites extending beyond the main confines of the tumor.

Symptoms

Patients usually note a deep seated mass in their soft tissue. Only when the tumor is very large do symptoms of pain or functional disturbances occur.

Retroperitoneal tumors may present with signs of weight loss and emaciation and abdominal pain. These tumors may also compress the kidney or ureter leading to kidney failure.

Incidence/Prevalence

Most frequent in middle-aged and older adults (age 40 and above), liposarcomas are the most common of all soft-tissue sarcomas. Annually 2.5 cases occur per million population.

Prognosis

The prognosis varies depending on the site of origin, the type of cancer cell, the tumor size, the depth, and proximity to lymph nodes. Metastases are common. The 5 year survival rate for a deep and high-grade liposarcoma is less than 50%.

Read more at Wikipedia.org


[List your site here Free!]


Primary liposarcoma of the liver: A case report and review of the literature
From Archives of Pathology & Laboratory Medicine, 3/1/01 by Nelson, Viera

* Liposarcoma is a rare mesenchymal malignant tumor, which usually originates in the retroperitoneum and the extremities. Seven cases of primary liposarcoma of the liver have been previously reported. We present the eighth case, which occurred in an adult female patient. Primary liposarcoma of the liver, although extremely rare, must be considered in the differential diagnosis of a hepatic mass that develops in a noncirrhotic liver, especially in patients who are potential candidates for orthotopic liver transplantation. Liposarcoma is an absolute contraindication for liver transplantation.

(Arch Pathol Lab Med. 2001;125:410-412)

REPORT OF A CASE

A 54-year-old African American woman presented 1 year before admission with abdominal distention, pain, nausea, vomiting, and a 10-lb weight loss. Her only risk factor for liver disease was ingestion of 150 g of alcohol per day, which she discontinued when the abdominal symptoms began. She did not seek medical attention until 3 months before the admission, when her symptoms worsened. On examination, she was not icteric, and there were no stigmata of chronic liver disease. Careful examination of the limbs and buttocks did not reveal lymphadenopathy or soft tissue masses. The abdomen was distended, firm, and tender. A large mass was palpable in the epigastrium and right upper quadrant. There was no ascites, edema, or splenomegaly. Complete blood cell count and standard serum liver test values, including albumin, prothrombin time, and at-fetoprotein, were all within the reference range. A computed tomographic scan of the abdomen revealed a 16-cm solid mass that involved the left lobe and a 3-cm lesion in the right lobe of the liver. An ultrasoundguided liver biopsy failed to provide sufficient diagnostic material. The patient was subsequently transferred to Cedars-Sinai Medical Center for further evaluation and possible liver resection.

A second computed tomographic scan showed that the left lobe mass had increased to 24 cm, with extensive hemorrhage. At that point, exploratory laparotomy and hepatic resection were considered. Laparotomy performed for tissue diagnosis revealed an extensive liver tumor with no obvious extrahepatic extension or distant metastases. The tumor was deemed to be unresectable, and a wedge liver biopsy specimen was obtained. The postoperative course was complicated by continuous bleeding and eventual cardiac arrest and death.

PATHOLOGIC FINDINGS

Permission for autopsy, limited to the abdomen, was obtained. External examination of the body did not demonstrate any palpable masses in the extremities or in the buttocks. The liver weighed 2400 g and the spleen 250 g. The capsule of the superior portion of the right and left liver lobes was infiltrated by an 27 x 15 X 15-cm tumor. Cut section of the tumor revealed a yellow-tan, fleshy, partially lobulated mass that showed scattered, irregular areas of hemorrhage, alternating with areas of necrosis. Several small 2- to 3-cm satellite tumor nodules were present in both lobes of the liver and in the omentum. Surrounding nonneoplastic liver parenchyma was grossly unremarkable and noncirrhotic.

HISTOPATHOLOGIC EXAMINATION, IMMUNOHISTOCHEMISTRY, AND ELECTRON MICROSCOPY

The tumor exhibited a plexiform vascular pattern and myxoid stroma. Lipoblasts were seen in varying stages of differentiation (Figure 1, A). Abundant myxoid stroma was present between tumor cells. The cytoplasm of the lipoblasts was for the most part granular, with nuclei indented by fat vacuoles. Some tumor cells were spindled, and others showed bizarre cell nuclei with occasional giant cell formation (Figure 1, B). Antibody to vimentin (mesenchymal cell marker) was demonstrable in many tumor cells and anti-a-smooth muscle actin (smooth muscle marker) was focally reactive. Immunostains for 5100 (neuroepithelial marker), keratin, HMB-45 (marker for melanoma), and CD34 (endothelial cell marker) were nonreactive. Electron microscopy showed typical lipoblasts with varying numbers of intracellular lipid droplets (Figure 2) and myxomatous stroma with a few collagen filaments. Smooth muscle filaments were not identified. There was no evidence of tumor elsewhere in the abdominal cavity and retroperitoneum. The diagnosis of myxoid liposarcoma was made.

COMMENT

Virchow, in 1857, first described a malignant tumor of fatty tissue arising in the lower extremity.1 Since then, liposarcomas have been identified in a number of tissue and organs, but only rarely in the liver.2 The most common sites are the deep soft tissue of the trunk and retroperitoneum and the subcutaneous fat of the upper and lower extremities.4 Liposarcomas account for 15% of all sarcomas and are most prevalent in the fifth decade. The prognosis of liposarcoma is dismal without treatment.2 The 5-year survival rate of patients who have undergone curative resection or radiation therapy for liposarcoma is approximately 50%.1 Metastatic spread of soft tissue liposarcomas is relatively common, but the liver is involved in only 10% of cases.' Metastases are usually found in the brain, pleura, thyroid gland, pancreas, and spinal cords There have been many attempts to classify liposarcomas, all reflecting a combination of 2 basic histological aspects of the tumor: (1) the stage of the differentiation of lipoblasts, based on relative amounts of lipid in the cells and myxoid material in the extracellular spaces, and (2) the overall degree of cellularity and cellular pleomorphism. Five major histological categories of liposarcomas are recognized: (1) myxoid, (2) round cell, (3) well-differentiated, (4) dedifferentiated, and (5) pleomorphic.6

Four cases of primary liposarcoma of the liver have been previously reported in adults.37-9 Wolloch et a13 in 1973 reviewed 16 cases of malignant liver tumors, including one patient with myxoid liposarcoma who had undergone right hepatic lobectomy with only 46 days postoperative survival. Kim et a 17 described a 14 X 10 x 5-cm liposarcoma of the right lobe of the liver. The patient subsequently underwent a hepatic resection and remained tumor free for 10 months.

Primary liposarcomas of the liver have also been described in children. Soares et all" described a case of a liposarcoma of the hepatic hilum that presented as obstructive jaundice in a 28-month-old infant. Wright et al11 described a 3-year-old boy who presented with abdominal pain, later proved to be due to liposarcoma in the hilum. Chen et al12 evaluated primary malignant tumors in the pediatric population. They described one child with liposarcoma, but sex, age, and exact location within the liver were not described. To our knowledge, there are no reports of hepatic liposarcoma in principal reference sources of rare hepatic tumors.13-15

We report a case of primary liposarcoma of the liver in an adult, perhaps the largest such tumor yet reported (Table). Although primary liposarcoma of the liver is exceedingly rare, this tumor should be considered in the differential diagnosis, especially in those patients who are potential candidates for liver resection or orthotopic liver transplantation.

References

1. Brasfield R, Das Gupta TK. Liposarcoma. CA Cancer J Clin. 1970;20:3-9.

2. Evans HL. Liposarcoma: a study of 55 cases with reassessment of its classification. Am J Pathol. 1979;3:507-523.

3. Wolloch Y, Dintsman M, Garti I. Primary malignant tumors of the liver. Isr J Med Sci. 1973;1:6-11.

4. Enzinger FM, Winslow DL. Liposarcoma: a study of 103 cases. Virchows Arch Surg Pathol Anat 1962;335:367-388.

5. Teas S, Ronan SG, Ghosh L. Solitary metastatic liposarcoma of the liver. Arch Pathol Lab Med. 1978; 102:605.

6. Enzinger FM, Weiss SW. Soft Tissue Tumors. 3rd ed. St Louis, Mo: Mosby; 1995:431-465.

7. Kim Yi, Yu ES, Lee KW, Park EU, Song HG. Dedifferentiated liposarcoma of the liver. Cancer. 1987;60:2785-2790.

8. Kim TW, Reyes CV. Myxoid liposarcoma mimicking fluid density. J Surg Oncol. 1985;30:80-82.

9. Aribal E. Primary liposarcoma of the liver. Am J Radiol. 1993;161:13311332.

10. Soares FA, Magnani Landell GA, Peres LC, Olivera MA, Vincente YAMVA, Tone LG. Liposarcoma of hepatic hilum in childhood: report of a case and review of literature. Med Pediatr Oncol. 1989;17:239-243.

11. Wright NB, Skinner R, Lee RE, Craft AW. Myxoid liposarcoma of the portal hepatis in childhood. Pediatr Radiol. 1993;23:620-621.

12. Chen WJ, Lee JC, Hung WT. Primary malignant tumor of liver in infants and children in Taiwan. J Pediatr Surg. 1988;23:457-461.

13. Craig JR, Peters RL, Edmondson HA. Tumors of the liver and intrahepatic bile ducts. In: Atlas of Tumor Pathology, Second Series, Fascicle 26. Washington, DC: Armed Forces Institute of Pathology; 1989.

14. Okuda K, Tabor E. Liver Cancer. New York, NY: Churchill Livingstone; 1997.

15. Fischer W, Gerlach W, Gruber GB, et al. Leber. In: Abelsdorff G, Albertini AV, Askenazy M, et al, eds. Henke and Lubarsch Handbuch der Speziellen Pathologischen Anatomie and Histologie. Berlin, Germany: Verlag von Julius Springer; 1930.

Accepted for publication July 18, 2000,

From the Department of Pathology and Laboratory Medicine (Drs Nelson, Geller, and Petrovic) and Division of Gastroenterology, Department of Medicine (Drs Fernandes and Woolf), Cedars-Sinai Medical Center, Los Angeles, Calif.

Reprints: Lydia M Petrovic, MD, Department of Pathology, Mayo Clinic, 200 First St SW, Rochester, MN 55905.

Copyright College of American Pathologists Mar 2001
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Liposarcoma
Home Contact Resources Exchange Links ebay